title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
66 Biggest Movers From Friday,20220523T075758,https://www.benzinga.com/news/22/05/27341379/66-biggest-movers-from-friday,DERM,0.054477,Neutral,0.003793
"The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics",20231227T134900,https://www.zacks.com/stock/news/2202519/the-zacks-analyst-blog-highlights-amphastar-pharmaceuticals-journey-medical-centessa-pharmaceuticals-and-aquestive-therapeutics,DERM,0.272788,Somewhat-Bullish,0.214209
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?,20231226T142900,https://www.zacks.com/stock/news/2202167/what-awaits-these-4-drug-stocks-that-more-than-doubled-in-2023,DERM,0.254973,Somewhat-Bullish,0.227856
Journey Medical  ( DERM )  Up on Update for Skin Disease Candidate,20231207T141600,https://www.zacks.com/stock/news/2194715/journey-medical-derm-up-on-update-for-skin-disease-candidate,DERM,0.504646,Neutral,0.111551
Stocks That Hit 52-Week Lows On Thursday,20220505T153818,https://www.benzinga.com/markets/options/22/05/27026106/52-weeks-high-and-low-article,DERM,0.015457,Neutral,0.002457
AstraZeneca's  ( AZN )  sBLA for Enhertu Gets FDA's Priority Tag,20240130T124400,https://www.zacks.com/stock/news/2217677/astrazenecas-azn-sbla-for-enhertu-gets-fdas-priority-tag,DERM,0.213517,Neutral,0.05874
Apellis  ( APLS )  Down on Negative CHMP Opinion for Pegcetacoplan,20240129T134800,https://www.zacks.com/stock/news/2216945/apellis-apls-down-on-negative-chmp-opinion-for-pegcetacoplan,DERM,0.159218,Neutral,0.059324
Heron  ( HRTX )  Gains 19% on FDA Nod for Zynrelef Label Expansion,20240125T114400,https://www.zacks.com/stock/news/2215517/heron-hrtx-gains-19-on-fda-nod-for-zynrelef-label-expansion,DERM,0.222327,Neutral,0.058902
